EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Review on Current Progress, Bottlenecks, and Future Prospects of Using Algorithmic and Computational Optimization of Drug Delivery Systems

Pooja Gupta, Aditya Narayan, Falguni Jaiswal, Rutva Gajjar, Priyanshi Patel

Journal of Pharma Insights and Research · 05.06.2026 · 4 (3) · 430-441

DOI: 10.69613/fzn2zv02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.06.2026. Verfasst von Pooja Gupta und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern drug delivery paradigms increasingly depend on algorithmic computation to resolve longstanding challenges in bioavailability, target site specificity, and controlled release dynamics. Advanced artificial intelligence models, including machine learning ensembles, deep neural networks, and reinforcement learning, enable predictive modeling of critical formulation variables, nanoparticle assemblies, and pharmacokinetics. Integrations of computational models with physiologically based pharmacokinetic models facilitate precise mapping of absorption, distribution, metabolism, excretion, and toxicity profiles prior to experimental execution. The convergence of computational intelligence with bio-fabrication techniques, such as three-dimensional bioprinting, allows the precise spatial arrangement of therapeutics within bio-compatible matrices, while closed-loop systems linked to the Internet of Medical Things permit real-time dosage adjustments driven by continuous physiological inputs. Despite these advancements, significant bottlenecks impede widespread clinical translation, notably data heterogeneity, algorithmic opacity, material degradation complexities, and evolving regulatory standards for adaptive software architectures. Addressing these limitations requires robust physics-informed neural networks, standardized data repositories, and transparent explainability models to validate computational predictions against empirical biological outcomes. Algorithmic drug delivery represents a fundamental shift from empirical formulation design toward precise, patient-specific therapeutic interventions

Zitieren

APA

Gupta, P., Narayan, A., Jaiswal, F., Gajjar, R., & Patel, P. (2026). A Review on Current Progress, Bottlenecks, and Future Prospects of Using Algorithmic and Computational Optimization of Drug Delivery Systems. Journal of Pharma Insights and Research, 4(3), 430-441. https://doi.org/10.69613/fzn2zv02

Vancouver

Gupta P, Narayan A, Jaiswal F, Gajjar R, Patel P. A Review on Current Progress, Bottlenecks, and Future Prospects of Using Algorithmic and Computational Optimization of Drug Delivery Systems. Journal of Pharma Insights and Research. 2026;4(3):430-441. doi:10.69613/fzn2zv02

BibTeX
@article{Gupta2026,
  author = {Gupta, Pooja and Narayan, Aditya and Jaiswal, Falguni and Gajjar, Rutva and Patel, Priyanshi},
  title = {A Review on Current Progress, Bottlenecks, and Future Prospects of Using Algorithmic and Computational Optimization of Drug Delivery Systems},
  journal = {Journal of Pharma Insights and Research},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {430--441},
  doi = {10.69613/fzn2zv02}
}
Kostenlos starten →